Comprehensive analyses supported miR-98’s important role in regulating tumor growth, invasion, and angiogenesis by down-regulating ALK4 and MMP11, as well as its potential predictive value as a biomarker in breast cancer patients [39, 43]. This evidence concerns the gene MMP11 and breast cancer.